Yoshinori Aono Selected Research

Yoshinori Aono Research Topics

Disease

12	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 06/2005
5	Inflammation (Inflammations) 11/2021 - 06/2005
5	Fibrosis (Cirrhosis) 01/2017 - 06/2005
4	Idiopathic Pulmonary Fibrosis 01/2018 - 03/2012
3	Airway Remodeling 11/2021 - 11/2014
3	Neoplasms (Cancer) 01/2018 - 01/2011
3	Lung Neoplasms (Lung Cancer) 01/2018 - 05/2013
2	Malignant Mesothelioma 12/2015 - 06/2013
2	Body Weight (Weight, Body) 01/2013 - 05/2006
2	Pneumonia (Pneumonitis) 01/2012 - 05/2006
1	Hypertrophy 01/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Rheumatoid Arthritis 03/2014
1	Radiation Injuries (Radiation Sickness) 01/2012
1	Hematologic Neoplasms (Hematological Malignancy) 01/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2005
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2005
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 02/2005
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 05/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2003

Drug/Important Bio-Agent (IBA)

11	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 06/2005
5	Tyrosine Kinase InhibitorsIBA 01/2017 - 05/2003
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 06/2005
3	CollagenIBA 01/2020 - 11/2014
3	Platelet-Derived Growth FactorIBA 01/2018 - 01/2013
3	Imatinib Mesylate (Gleevec)FDA Link 12/2014 - 06/2005
3	CytokinesIBA 03/2014 - 05/2006
3	indium-bleomycinIBA 10/2013 - 06/2005
2	AllergensIBA 11/2021 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2011
2	nintedanibIBA 01/2018 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 01/2018 - 01/2011
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2018 - 01/2015
2	LigandsIBA 01/2018 - 02/2005
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2014 - 03/2012
2	Gefitinib (Iressa)FDA Link 01/2012 - 05/2003
2	ErbB Receptors (EGF Receptor)IBA 01/2012 - 05/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Fluticasone (Cutivate)FDA LinkGeneric 11/2021
1	Interleukin-33IBA 11/2021
1	ICG 001IBA 01/2019
1	CateninsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Blocking AntibodiesIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	OsteopontinIBA 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	Bevacizumab (Avastin)FDA Link 12/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2015
1	2- ((3- (4- tert- butylphenoxy)- 4'- (trifluoromethoxy)(1,1'- biphenyl)- 4- yl)oxy)acetic acidIBA 01/2015
1	Plasminogen Activator Inhibitor 1IBA 01/2015
1	Messenger RNA (mRNA)IBA 12/2014
1	Interleukin-13IBA 11/2014
1	Inflammation MediatorsIBA 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014
1	Thymidine PhosphorylaseIBA 03/2014
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2013
1	TAE226IBA 10/2013
1	SialomucinsIBA 06/2013
1	Glycoproteins (Glycoprotein)IBA 06/2013
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 05/2013
1	plerixafor FDA Link 01/2013
1	Clarithromycin (Biaxin)FDA LinkGeneric 12/2007
1	Erythromycin (Erycette)FDA LinkGeneric 12/2007
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 05/2006
1	NF-kappa B (NF-kB)IBA 05/2006
1	I-kappa B KinaseIBA 05/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2005
1	Bromodeoxyuridine (BrdU)IBA 06/2005
1	Chemokine CCL17IBA 02/2005
1	Chemokine CCL22IBA 02/2005
1	CCR4 ReceptorsIBA 02/2005

Therapy/Procedure

4	Therapeutics 01/2019 - 12/2007
1	Molecular Targeted Therapy 01/2011
1	Drug Therapy (Chemotherapy) 05/2003